Formulation and Delivery
Can Araman, PhD
Senior Manager, Laboratory Head Protein Formulations R&D
MilliporeSigma
Darmstadt, Hessen, Germany
In this presentation, challenges arising from elevated protein viscosity on patient compliance and process economics will be discussed. Furthermore, a platform of excipient combinations to overcome above limitations via viscosity reduction while maintaining stability will be introduced. Specifically, benefits of aforementioned excipient combinations for high concentration & low viscosity antibody formulations when using TFF will be highlighted. Moreover, a machine-learning based digital application for viscosity reduction, which minimizes the number of experiments, will be introduced.